Key facts
- This page summarizes Christoph H. Westphal's Form 4 filing for TScan Therapeutics, Inc. (TCRX).
- 5 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 22 Jul 2021, 16:46.
Christoph H. Westphal - 20 Jul 2021 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- TCRX
- Reported as of
- 20 Jul 2021
- Net transaction value
- +$1,999,995
- SEC form
- 4
- Accepted by SEC
- 22 Jul 2021, 16:46:41 UTC
- Prior SEC filing
- 15 Jul 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christoph Westphal
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christoph H. Westphal filed Form 4 for TScan Therapeutics, Inc. (TCRX) on 22 Jul 2021.
Change
- Previous filing in this sequence was filed on 15 Jul 2021.
- Current net transaction value: +$1,999,995.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TCRX
transaction
Voting Common Stock
Conversion of derivative security
- Transaction value
- Shares
- +1,145,505
- Change %
- Price
- Shares after
- 1,145,505
- Date
- 20 Jul 2021
- Ownership
- See footnote
- Footnotes
- F2, F3
TCRX
transaction
Voting Common Stock
Purchase
- Transaction value
- $1,999,995
- Shares
- +133,333
- Change %
- +12%
- Price
- $15.00
- Shares after
- 1,278,838
- Date
- 20 Jul 2021
- Ownership
- See footnote
- Footnotes
- F3, F4
TCRX
holding
Voting Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 914,634
- Date
- 20 Jul 2021
- Ownership
- Direct
TCRX
holding
Voting Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 121,951
- Date
- 20 Jul 2021
- Ownership
- See footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TCRX
transaction
Derivative
Series A Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -641,848
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- See footnote
- Underlying class
- Voting Common Stock
- Underlying amount
- 641,848
- Exercise price
- Footnotes
- F2, F3
TCRX
transaction
Derivative
Series B Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -332,594
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- See footnote
- Underlying class
- Voting Common Stock
- Underlying amount
- 332,594
- Exercise price
- Footnotes
- F2, F3
TCRX
transaction
Derivative
Series C Preferred Stock
Conversion of derivative security
- Transaction value
- Shares
- -171,063
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 20 Jul 2021
- Ownership
- See footnote
- Underlying class
- Voting Common Stock
- Underlying amount
- 171,063
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These shares are held by the Reporting Person's spouse.
Footnote F2
Each share of the Issuer's preferred stock automatically converted on a one for one basis into Voting Common Stock immediately prior to the closing of the Issuer's initial public offering, without payment or further consideration. The preferred stock had no expiration date.
Footnote F3
These shares are held by Longwood Fund IV, L.P. ("Longwood"). The general partner of Longwood is Longwood Fund IV GP, LLC ("Longwood GP"). Voting, investment and dispositive decisions at Longwood GP with respect to the securities held by Longwood are made by an investment committee comprised of Christoph Westphal, Richard Aldrich and John Lawrence (collectively, the "IC Members"). Longwood GP and each of the IC Members may be deemed to share voting, investment and dispositive power over the securities held by Longwood and as a result may be deemed to have beneficial ownership over such securities. Longwood GP and each of the IC Members disclaims beneficial ownership over the securities held by Longwood, except to the extent of their respective pecuniary interests therein.
Footnote F4
Represents shares purchased in the Issuer's initial public offering.